Autoimmune disease after autologous hematopoietic stem cell transplantation. 2008

Toshiyuki Bohgaki, and Tatsuya Atsumi, and Takao Koike
Department of Medicine II, Hokkaido University Graduate School of Medicine N-15 W-7, Kita-ku, Sapporo 060-8638, Japan. tbohgaki@uhnres.utoronto.ca

Hematopoietic stem cell transplantation (HSCT) is an effective treatment for refractory autoimmune diseases. The safety and long-term outcome have been also acceptable. Infectious diseases under immune suppressive state after autologous HSCT are common transplantation related complications whereas autoimmune diseases are uncommon. Organ specific autoimmune diseases, such as immune mediated thrombocytopenia and thyroid dysfunction, are the most common after autologous HSCT. Systemic autoimmune diseases can also develop after autologous HSCT in patients with hematological disorders with genetic predisposition to autoimmune diseases. Although the mechanism of autoimmunity after HSCT is not well-known, long-term follow-up is essential in patients with autoimmune diseases treated with autologous HSCT.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001327 Autoimmune Diseases Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides. Autoimmune Disease,Disease, Autoimmune,Diseases, Autoimmune
D014182 Transplantation, Autologous Transplantation of an individual's own tissue from one site to another site. Autografting,Autologous Transplantation,Autotransplantation,Autograftings,Autologous Transplantations,Autotransplantations,Transplantations, Autologous

Related Publications

Toshiyuki Bohgaki, and Tatsuya Atsumi, and Takao Koike
February 2010, Pediatric clinics of North America,
Toshiyuki Bohgaki, and Tatsuya Atsumi, and Takao Koike
January 2000, Journal of clinical immunology,
Toshiyuki Bohgaki, and Tatsuya Atsumi, and Takao Koike
December 2009, Expert review of hematology,
Toshiyuki Bohgaki, and Tatsuya Atsumi, and Takao Koike
January 2005, Acta haematologica,
Toshiyuki Bohgaki, and Tatsuya Atsumi, and Takao Koike
May 2005, Bone marrow transplantation,
Toshiyuki Bohgaki, and Tatsuya Atsumi, and Takao Koike
July 2021, Bone marrow transplantation,
Toshiyuki Bohgaki, and Tatsuya Atsumi, and Takao Koike
December 2022, Journal of clinical and experimental hematopathology : JCEH,
Toshiyuki Bohgaki, and Tatsuya Atsumi, and Takao Koike
January 2020, Revista da Sociedade Brasileira de Medicina Tropical,
Toshiyuki Bohgaki, and Tatsuya Atsumi, and Takao Koike
January 2016, Current research in translational medicine,
Toshiyuki Bohgaki, and Tatsuya Atsumi, and Takao Koike
January 2022, Pediatrics international : official journal of the Japan Pediatric Society,
Copied contents to your clipboard!